|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, July 14, 2018 ) Browse 70 Market Data Tables and 34 Figures spread through 131 Pages and in-depth TOC on "Surgical Imaging Market"
https://www.marketsandmarkets.com/Market-Reports/surgical-imaging-market-210534462.html
Early buyers will receive 10% customization on this report.
Based on the revenues gained from surgical imaging products, the overall surgical imaging market is dominated by four major players contributing to approximately 74% of the surgical imaging market. These players include GE Healthcare (U.K.), Siemens AG (Germany), Philips (Netherlands), and Ziehm Imaging (Germany).
The leading position of GE Healthcare can be attributed to its strong product portfolio, which includes its flagship product, OEC 9900 Elite. The OEC 9900 Elite provides improved image quality and optimal dose management. This translates to improved patient care. In November 2012, the company launched OEC Brivo 865 Advance, a new mobile C-arm developed as an affordable option for orthopedic surgical imaging. In this manner, the company has developed mobile C-arms to suit every application and price range of their customers.
The company has a strong focus on innovation and raising the bar in terms of quality of product delivered. An independent study conducted by University of Texas and presented at the North American Spine Society-2012, rated OEC Elite 9900 as the best in dose management and image quality. These developments in image quality and dose management translate to improved quality of patient care. Furthermore, The company has wide geographic presence in the regions of North America, Europe, Middle East, Africa, Asia-Pacific, and Latin America.
Download the PDF Brochure@
https://www.marketsandmarkets.com/pdfdownload.asp?id=210534462
Siemens AG and Koninklijke Philips N.V. are the other leadings player in this market. They have a wide portfolio of mobile C-arms and are equipped with both the age old image intensifier and the current flat detector technology. Siemens AG has a strong focus on innovation and gaining FDA approvals. The company’s flag ship mobile C-arm, Cios Alpha, and delivers excellent image quality at low dosage. It was the recipient of the iF Product Design Award 2014. Furthermore, Siemens also received FDA approval in April 2014.
Koninklijke Philips strategically focuses on high growth markets. Emerging markets such as China and India are of particular interest to Philips and it is taking measures to tap into the huge growth potential in these regions. As of 2013, the company has already established a research and development centre and a manufacturing unit in India to increase its footprint in the growing Indian market. Germany based Ziehm Imaging is one of the fast growing players in the surgical imaging market. The company uses an aggressive expansion strategy to enter new geographies.
For instance, in April 2013, Ziehm Medical Shanghai, the company’s subsidiary, opened a new branch office in Guangzhou, China. The new facility is likely to increase the company’s footprint in the Southern Chinese market. The other prominent players in the market include Toshiba Corporation (Japan), Shimadzu Corporation (Japan), Hologic, Inc. (U.S.), OrthoScan (U.S.) and Eurocolumbus (Italy).
Get the Sample Pages@
https://www.marketsandmarkets.com/requestsample.asp?id=210534462
North America to dominate the market in 2017
North America is expected to account for the largest share of the surgical imaging market in 2017, followed by Europe, Asia Pacific (APAC), and the Rest of the World. The large share of this region can be attributed to a rising number of overuse sports injuries, and rising prevalence of CVD, along with the increasing number of cardiac arrest cases, and increase in the number of minimally invasive procedures performed in Canada.
However, Asia Pacific is expected to register the highest CAGR of 7.1% during the forecast period, owing to the rapid growth in geriatric population in Japan, healthcare reforms in China, improving healthcare infrastructure in India, and rising number of orthopedic and CVD procedures in Australia.
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
MarketsandMarkets
Mr. Shelly Singh
1-888-600-6441
sales@marketsandmarkets.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
